-

Groupe Berkem Considers Merging Its Main Subsidiaries to Rationalize the Group’s Structure

  • Potential reorganization into four high-potential business areas:
    • Construction & Materials
    • Health, Beauty & Nutrition
    • Hygiene & Protection
    • Industry
  • Strong synergies between the Group's various activities
  • Reaffirmation of Groupe Berkem's mission: "Integrating bio-based chemistry into conventional chemistry"

BLANQUEFORT, France--(BUSINESS WIRE)--Regulatory News:

Groupe Berkem, a leading player in bio-based chemistry (ISIN code: FR00140069V2 - Ticker: ALKEM), announces today that it is considering merging its main subsidiaries, BERKEM, EUROLYO, LIXOL and ADKALIS, grouped together within their parent company BERKEM DEVELOPPEMENT (a wholly owned subsidiary of Groupe Berkem), according to a schedule currently being drawn up.

Through this internal restructuring, Groupe Berkem intends to simplify its organization and optimize interactions between its various business areas. As an expert in bio-based chemistry, Groupe Berkem contributes to the ongoing ecological transition. The synergies created between the various business lines and activities thanks to the Group's diversified expertise enable it to address the many needs of companies in terms of sustainability and to respond effectively to their expectations.

This project is a continuation of the reorganization carried out in recent months, which structures the Group around four high-potential core businesses:

- Construction & Materials Division: formulation of solutions for the protection, decoration and maintenance of wood and mineral materials at all stages in the life of buildings and construction materials;

- Health, Beauty & Nutrition Division: development of active plant ingredients for cosmetics, nutraceuticals and the food industry;

- Hygiene & Protection Division: production of solutions dedicated to protecting people, foodstuffs and products against pests and damage caused by fungi;

- Industry: resin synthesis for the printing ink market, or even technical vegetable oils and solutions for the adhesive and road marking markets...

Olivier FAHY, Chairman and CEO of Groupe Berkem, comments: "Groupe Berkem has built its identity around strong expertise, strengthened over the years by targeted acquisitions that have enabled us to address high-potential market niches. With the recent acquisitions of i.Bioceuticals and Biopress and the intensification of our international strategy, symbolized by our recent joint venture in the Ivory Coast, we felt it was essential to restructure our organization. In addition to simplifying our Group’s operations, the aim of this merger is to unite us around a common project, namely, to integrate bio-based chemistry into conventional chemistry. We know that our unique expertise and that the many possible synergies between our different industrial activities will enable us to respond even more effectively to the issues facing industry today in terms of the ecological transition".

ABOUT GROUPE BERKEM

Founded in 1993 by Olivier Fahy, Chairman and Chief Executive Officer, Groupe Berkem is a leading force in the bio-based chemicals market. Its mission is to advance the environmental transition of companies producing the chemicals used in everyday life (Construction & Materials, Health, Beauty & Nutrition, Hygiene & Protection, and Industry). By harnessing its expertise in both plant extraction and innovative formulations, Groupe Berkem has developed bio-based boosters—unique high-quality bio-based solutions augmenting the performance of synthetic molecules. Groupe Berkem achieved revenue of €51.8 million in 2022. The Group has almost 200 employees working at its head office (Blanquefort, Gironde) and 4 production facilities in Gardonne (Dordogne), La Teste-de-Buch (Gironde), Chartres (Eure-et-Loir) and Tonneins (47).

Groupe Berkem has been listed on Euronext Growth Paris since December 2021 (ISIN code: FR00140069V2 - ALKEM).
www.groupeberkem.com

Contacts

Groupe Berkem
Olivier Fahy, Chairman and CEO
Anthony Labrugnas, Chief Financial Officer
Phone: +33 (0)5 64 31 06 60
investisseurs@berkem.com

NewCap
Investor Relations
Mathilde Bohin / Nicolas Fossiez
Phone: +33 (0)1 44 71 94 94
berkem@newcap.eu

NewCap
Media Relations
Nicolas Merigeau / Antoine Pacquier
Phone: +33 (0)1 44 71 94 94
berkem@newcap.eu

Groupe Berkem

BOURSE:ALKEM

Release Versions

Contacts

Groupe Berkem
Olivier Fahy, Chairman and CEO
Anthony Labrugnas, Chief Financial Officer
Phone: +33 (0)5 64 31 06 60
investisseurs@berkem.com

NewCap
Investor Relations
Mathilde Bohin / Nicolas Fossiez
Phone: +33 (0)1 44 71 94 94
berkem@newcap.eu

NewCap
Media Relations
Nicolas Merigeau / Antoine Pacquier
Phone: +33 (0)1 44 71 94 94
berkem@newcap.eu

More News From Groupe Berkem

Result of the Simplified Tender Offer on Groupe Berkem Shares

BLANQUEFORT, France--(BUSINESS WIRE)--Regulatory News: Groupe Berkem (ISIN code: FR00140069V2 - mnemonic: ALKEM) (the “Company”), a leading player in plant-based chemistry, announces that the Autorité des marchés financiers (AMF) has today published the final result of the simplified tender offer on Groupe Berkem shares (the “Offer”) initiated by Kenerzeo (the “Offeror”). At the close of the Offer, opened from December 9, 2024, to December 20, 2024 included, Kenerzeo individually holds a total...

Groupe Berkem Launches RECELLCL'IN®, Its New Active Ingredient Dedicated to the Cosmetic Market

BLANQUEFORT, France--(BUSINESS WIRE)--Regulatory News: Groupe Berkem (Paris:ALKEM), a leading player in bio-based chemistry (ISIN code: FR00140069V2 – Ticker: ALKEM), today announced the launch of RECELLCL'IN®, a new active ingredient for the beauty industry. Marlène De Matos, Groupe Berkem's Active Ingredient Development & Innovation R&D Manager, stated: “For this product launch, we drew the power of polyphenols from the heart of passiflora, to turn a traditionally used plant into an i...

Groupe Berkem Announces Its Revenue of €40.4 Million as of September 30, 2024

BLANQUEFORT, France--(BUSINESS WIRE)--Regulatory News: Groupe Berkem, a leading player in bio-based chemistry (ISIN code: FR00140069V2 – Ticker: ALKEM), announces its revenue as of September 30, 2024, and provides an update on its recent activity. 2024 THIRD-QUARTER REVENUE As of September 30, 2024, Groupe Berkem’s revenue for the first nine months of 2024 reached €40.4 million, against €39.9 million over the same period in 2023, i.e. an increase of +1.2%. Repartition of revenue per business ar...
Back to Newsroom